Phenylphosphonic Acid

Phenylphosphonic Acid

SCHEMBL2790969

O=P(O)(O)c1ccccc1.[SnH4]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.94
CA4 P22748 1/20 0.94
CA5A P35218 1/20 0.94
CFTR P13569 1/20 0.56
ALOX15 P16050 1/20 0.52
TSHR P16473 1/20 0.52
ALDH1A1 P00352 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
PGK1 P00558 1/20 0.47
PGK2 P07205 1/20 0.47
USP2 O75604 1/20 0.46
GAA P10253 1/20 0.46
ESR1 P03372 1/20 0.46
SRC P12931 2/20 0.44
LMNA P02545 1/20 0.43
PTPN1 P18031 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylphosphonic Acid SCHEMBL28151870 0.97 CA2 (1.00) CA2CA4CA5ACFTRALOX15
Phenylphosphonic Acid SCHEMBL34998 0.97 CA2 (1.00) CA2CA4CA5ACFTRALOX15
Phenylphosphonic Acid SCHEMBL269853 0.97 CA2 (1.00) CA2CA4CA5ACFTRALOX15
Phenylphosphonic Acid SCHEMBL109137 0.94 CA2 (0.94) CA2CA4CA5ACFTRALOX15
Phenylphosphonic Acid SCHEMBL2471813 0.94 CA2 (0.94) CA2CA4CA5ACFTRALOX15
Phenylphosphonic Acid SCHEMBL679819 0.94 CA2 (0.94) CA2CA4CA5ACFTRALOX15
Phenylphosphonic Acid SCHEMBL20140614 0.94 CA2 (0.94) CA2CA4CA5ACFTRALOX15
Phenylphosphonic Acid SCHEMBL11800527 0.94 CA2 (0.94) CA2CA4CA5ACFTRALOX15
Phenylphosphonic Acid SCHEMBL3397814 0.94 CA2 (0.94) CA2CA4CA5ACFTRALOX15
Phenylphosphonic Acid SCHEMBL4433564 0.94 CA2 (0.94) CA2CA4CA5ACFTRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851402-B2 Method for solubilizing metal oxides by surface treatment, surface treated metal oxide solutions and method for separating metal oxides NATIONAL UNIVERSITY OF IRELAND, GALWAY (IE) 2010-12-14 US disclosed
US-20080138600-A1 Soluble Metal Oxides and Metal Oxide Solutions NATIONAL UNIVERSITY OF IRELAND, GALWAY (IE) 2008-06-12 US disclosed
US-20070140937-A1 Method for solubilizing metal oxides by surface treatment, surface treated metal oxide solutions and method for separating metal oxides NATIONAL UNIVERSITY OF IRELAND, GALWAY (IE) 2007-06-21 US disclosed
EP-1685199-A2 METHOD FOR SOLUBILIZING METAL OXIDES BY SURFACE TREATMENT, SURFACE TREATED METAL OXIDE SOLUTIONS AND METHOD FOR SEPARATING METAL OXIDES The National University of Ireland, Galway (IE) 2006-08-02 EP disclosed
WO-2005049520-A2 METHOD FOR SOLUBILIZING METAL OXIDES BY SURFACE TREATMENT, SURFACE TREATED METAL OXIDE SOLUTIONS AND METHOD FOR SEPARATING METAL OXIDES THE NATIONAL UNIVERSITY OF IRELAND, GALWAY (IE) 2005-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080138600-A1 Soluble Metal Oxides and Metal Oxide Solutions ORAI1, TMCO1, ACHE CA2 77/4885CA4 408/4885CA5A 309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.